Viewing nowCombinationTwinmax Tablet 40/10 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 201605804 · Approved 2016.09.30 · Insurance code 663607100
Treatment of essential hypertension not controlled with monotherapy
This medication effectively lowers blood pressure and improves hypertension in patients with essential hypertension who do not have adequate blood pressure control with monotherapy of amlodipine or telmisartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older patients: The usual amlodipine dosage is recommended for older patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication should not be used during pregnancy, especially during the second and third trimesters, as it may cause severe risks to the fetus and newborn. Do not take if you are allergic to any ingredients in this medication, pregnant or breastfeeding, or have severe liver or heart problems. Caution is required when using this medication in patients with impaired liver function, gastrointestinal disorders, renal impairment, and elderly patients. During the course of this medication, side effects such as dizziness or peripheral edema can commonly occur, and rarely, serious side effects may arise, so consult a doctor immediately if unusual symptoms appear. Hypotensive symptoms may manifest if blood pressure drops too low, so if symptoms occur, lie down and rest immediately, and seek treatment at a hospital if necessary. This medication can raise potassium levels, so when taken with potassium-rich drugs or supplements, regular monitoring of serum potassium levels is necessary. Drug interactions may occur when taken with other medications, so inform your doctor or pharmacist of any current medications you are taking. Women who are pregnant or planning to become pregnant are recommended to switch to another antihypertensive with proven safety instead of this medication, and should discontinue use immediately if pregnancy is confirmed. Breastfeeding women should avoid taking this medication and should consult their doctor, especially if they are nursing. The safety and efficacy of this medication have not been sufficiently established in children and adolescents, so its use is not recommended. Elderly patients may be more sensitive to medications, so caution is required when taking this medication, and dose adjustment may be necessary. In cases of overdose, symptoms such as hypotension, dizziness, and heart function impairment may occur, so seek appropriate treatment at a hospital immediately. Keep this medication out of the reach of children, and do not transfer it to other containers to maintain the quality of the product. It is recommended to take the tablet directly from the sealed package.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a sealed container that blocks light. It is important to maintain storage temperatures between 1°C and 30°C at room temperature. This will help preserve the medication's efficacy and safety.
White and light gray double-layered oval tablet with a convex shape on both sides
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.